This content is brought to you in partnership with AVITA Medical.
Looking to treat your stable vitiligo and wondering if a clinical trial is right for you? Clinical trials – and participants in these trials – play a key role in advancing the future of vitiligo treatments. Clinical trials can also provide patients with access to the latest treatments still being researched. One of these is a procedure using the RECELL® System, which is now available for eligible participants through the RSVP Study.
The RSVP Study is a clinical trial evaluating an investigational device, named the RECELL® System, for the treatment of depigmented areas in patients with stable vitiligo. The multi-center study will assess the treatment of depigmented vitiligo lesions at 24 weeks in patients whose vitiligo is stable, meaning they have not had any new vitiligo lesions or increase in size of existing lesions for at least one year.
What is a clinical trial?
Clinical trials are carefully designed research studies that evaluate a medical intervention or treatment. Most clinical trials are created to determine if a new, experimental treatment for a disease is safe and effective, and if relevant, how it fares in comparison to existing treatments.
Clinical trials play a critical role in the development of treatments because there is currently no cure for vitiligo or FDA-approved treatments for repigmenting vitiligo. As a result, clinical trials provide research to explore new options for treatment. You can discuss clinical trials with your doctor to determine if they are right for you.
How does the RECELL® System work?
Clinicians will obtain a small amount of the patient’s own healthy skin and use it to prepare a suspension of Spray-On Skin™ Cells using the RECELL® System. Spray-On Skin™ Cells are then applied directly on the area of depigmented skin.
The RSVP study will allow researchers to assess the long-term safety and effectiveness of the RECELL® System, including whether the treatment is able to provide long-term repigmentation for those with stable vitiligo.
Do I qualify for the RSVP Study?
The RSVP study has specific qualifications that must be met to be eligible for the trial. You may be able to participate in the RSVP Study if all of the following criteria are met:
- You live in the United States
- You are 18 years of age or older
- You have stable vitiligo (no new areas or current areas not increasing size in the last 12 months)
- You have previously tried both topical treatments and phototherapy
- You can provide photos of your vitiligo that were taken more than 12 months ago (photographs can be your own or from your doctor)
Additional eligibility requirements must be met and will be reviewed with you by a study doctor.
Where is the RSVP Study located?
The multi-center study is being held at locations throughout the United States. Current locations for the study include: Austin, TX; Houston, TX; Denver, CO; Sacramento, CA; Los Angeles, CA; Irvine, CA; San Diego, CA; Hackensack, NJ; Detroit, MI; Chicago, IL; Worcester, MA; Westport, CT; Charlotte, NC; Charleston, SC; and Hollywood, FL.
How do I learn more about the RSVP Study?
To learn more about the RSVP study for vitiligo and see if you qualify, visit vitiligorsvpstudy.mmgct.com.
Erika Page is the Founder and Editor of Living Dappled. After getting vitiligo at the age of seven, she lost 100% of her pigment to the condition and today lives with universal vitiligo.